Koevary S B, Caspi R R
New England College of Optometry, Ocular Research Center, Boston MA 02115, USA. Koevarys@ne-optometry-edu
Ocul Immunol Inflamm. 1997 Sep;5(3):165-72. doi: 10.3109/09273949709116891.
The objective of this paper was to determine whether intrathymic injection of retinal S-antigen (S-Ag) can prevent experimental autoimmune uveoretinitis (EAU) in Lewis rats. Lewis rats were injected intrathymically with 25-100 micrograms of S-Ag in 100 microliters split between thymic lobes. Controls received vehicle alone (PBS) or 100 micrograms of BSA. Animals were immunized two weeks later with 100 micrograms of S-Ag in CFA with or without pertussis toxin (0.5 micrograms/rat). Clinical ocular disease was confirmed by histopathology. Splenocytes and lymph node cells were assayed, in vitro, for their ability to proliferate in response to various concentrations of S-Ag. Furthermore, attempts were made to adoptively transfer protection to naive rats using spleen cells from intrathymically injected animals and to adoptively transfer EAU to protected rats using Con A activated cells from affected animals. Intrathymic injection of S-Ag reduced the incidence of EAU in animals subsequently immunized with S-Ag and pertussis, and prevented it entirely in rats immunized in the absence of pertussis. Splenic and lymph node cells from intrathymically injected animals showed reduced reactivity to S-Ag compared to controls, suggesting that intrathymic S-Ag injection may have rendered them tolerant to this antigen. We were unable to adoptively transfer protection to naive rats, nor were intrathymically injected rats protected from EAU induced by the adoptive transfer of primed lymph node cells. These data demonstrate that intrathymic S-Ag injection can be an effective method for protection from EAU, apparently through the induction of immunological tolerance and not active suppression. The tolerance was not absolute and could be overcome by increasing the intensity of the antigenic challenge.
本文的目的是确定胸腺内注射视网膜S抗原(S-Ag)是否能预防Lewis大鼠的实验性自身免疫性葡萄膜视网膜炎(EAU)。将Lewis大鼠胸腺内注射25 - 100微克S-Ag,分100微升注入胸腺叶。对照组仅接受赋形剂(PBS)或100微克牛血清白蛋白。两周后,用100微克S-Ag在完全弗氏佐剂中免疫动物,同时或不添加百日咳毒素(0.5微克/只大鼠)。通过组织病理学确认临床眼部疾病。体外检测脾细胞和淋巴结细胞对不同浓度S-Ag的增殖能力。此外,尝试用胸腺内注射动物的脾细胞将保护作用过继转移给未免疫的大鼠,并用来自患病动物的刀豆蛋白A激活的细胞将EAU过继转移给受保护的大鼠。胸腺内注射S-Ag降低了随后用S-Ag和百日咳免疫的动物中EAU的发生率,并在无百日咳免疫的大鼠中完全预防了EAU。与对照组相比,胸腺内注射动物的脾细胞和淋巴结细胞对S-Ag的反应性降低,这表明胸腺内注射S-Ag可能使它们对该抗原产生了耐受性。我们无法将保护作用过继转移给未免疫的大鼠,胸腺内注射的大鼠也不能免受经致敏淋巴结细胞过继转移诱导的EAU的影响。这些数据表明,胸腺内注射S-Ag可能是预防EAU的有效方法,显然是通过诱导免疫耐受而非主动抑制。这种耐受性不是绝对的,可以通过增加抗原刺激的强度来克服。